Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controll... by Xu, Binghe, Prof, Yan, Min, Prof, Ma, Fei, Prof, Hu, Xichun, Prof, Feng, Jifeng, Prof, Ouyang, Quchang, Prof, Tong, Zhongsheng, Prof, Li, Huiping, Prof, Zhang, Qingyuan, Prof, Sun, Tao, Prof, Wang, Xian, MD, Yin, Yongmei, Prof, Cheng, Ying, Prof, Li, Wei, Prof, Gu, Yuanting, Prof, Chen, Qianjun, Prof, Liu, Jinping, Prof, Cheng, Jing, Prof, Geng, Cuizhi, Prof, Qin, Shukui, Prof, Wang, Shusen, Prof, Lu, Jinsong, Prof, Shen, Kunwei, Prof, Liu, Qiang, Prof, Wang, Xiaojia, Prof, Wang, Hong, Prof, Luo, Ting, Prof, Yang, Jin, Prof, Wu, Yudong, Prof, Yu, Zhiyong, Prof, Zhu, Xiaoyu, MD, Chen, Chunxia, MSc, Zou, Jianjun, MD

Get full text

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, plac... by Wang, Jie, Prof, Zhou, Caicun, Prof, Yao, Wenxiu, Prof, Wang, Qiming, Prof, Min, Xuhong, BS, Chen, Gongyan, Prof, Xu, Xingxiang, Prof, Li, Xingya, Prof, Xu, Fei, Prof, Fang, Yong, Prof, Yang, Runxiang, Prof, Yu, Guohua, Prof, Gong, Youling, Prof, Zhao, Jun, Prof, Fan, Yun, Prof, Liu, Quan, Prof, Cao, Lejie, Prof, Yao, Yu, Prof, Liu, Yunpeng, Prof, Li, Xiaoling, Prof, Wu, Jingxun, Prof, He, Zhiyong, Prof, Lu, Kaihua, Prof, Jiang, Liyan, Prof, Hu, Chengping, Prof, Zhao, Wenhua, MD, Zhang, Ben, Ms, Shi, Wei, MD, Zhang, Xiaojing, MD, Cheng, Ying, Prof

Get full text

Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final anal... by Zhou, Caicun, Prof, Wang, Ziping, Prof, Sun, Yuping, Prof, Cao, Lejie, Prof, Ma, Zhiyong, Prof, Wu, Rong, Prof, Yu, Yan, Prof, Yao, Wenxiu, Prof, Chang, Jianhua, Prof, Chen, Jianhua, Prof, Zhuang, Wu, BM, Cui, Jiuwei, Prof, Chen, Xueqin, Prof, Lu, You, Prof, Shen, Hong, MD, Wang, Jingru, PhD, Li, Peiqi, MD, Qin, Mengmeng, MMed, Lu, Dongmei, MSc, Yang, Jason, MD

Get full text

Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, pha... by Xu, Lai, MD, Su, Xiangqian, Prof, He, Zirui, MD, Zhang, Chenghai, MD, Lu, Junyang, MD, Zhang, Guannan, MD, Sun, Yueming, Prof, Du, Xiaohui, Prof, Chi, Pan, Prof, Wang, Ziqiang, Prof, Zhong, Ming, Prof, Wu, Aiwen, Prof, Zhu, Anlong, Prof, Li, Fei, Prof, Xu, Jianmin, Prof, Kang, Liang, MD, Suo, Jian, Prof, Deng, Haijun, MD, Ye, Yingjiang, Prof, Ding, Kefeng, Prof, Xu, Tao, MD, Zhang, Zhongtao, Prof, Zheng, Minhua, Prof, Xiao, Yi, Prof

Get full text